Detalles de la búsqueda
1.
Outcomes for Psoriasis by Self-Identified Racial Groups in Ixekizumab Clinical Trials: A Pooled Analysis.
J Drugs Dermatol;
23(2): 17-22, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38306141
2.
Early Response is Associated With Stable Long-Term Response in Psoriasis Patients Receiving Ixekizumab or Ustekinumab.
J Drugs Dermatol;
21(2): 122-126, 2022 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35133112
3.
Long-term efficacy and safety of ixekizumab: A 5-year analysis of the UNCOVER-3 randomized controlled trial.
J Am Acad Dermatol;
85(2): 360-368, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33253833
4.
Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 Studies.
J Drugs Dermatol;
20(4): 394-401, 2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33852247
5.
Sustained High Efficacy and Favorable Safety Over Five Years in Patients With Burdensome Psoriasis (UNCOVER-1/UNCOVER-2).
J Drugs Dermatol;
20(8): 880-887, 2021 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34397207
6.
Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort.
BMC Dermatol;
20(1): 3, 2020 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32434510
7.
The Static Physician's Global Assessment of Genitalia: A Clinical Outcome Measure for the Severity of Genital Psoriasis.
J Drugs Dermatol;
16(8): 793-799, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28809994
8.
Does Teriparatide Improve Femoral Neck Fracture Healing: Results From A Randomized Placebo-controlled Trial.
Clin Orthop Relat Res;
474(5): 1234-44, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26932738
9.
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor).
Dermatol Ther (Heidelb);
14(2): 441-451, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38332436
10.
Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60.
Dermatol Ther (Heidelb);
14(4): 1007-1018, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38647975
11.
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24-28 and 48-52 weeks.
J Dermatolog Treat;
34(1): 2263108, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37781881
12.
Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis.
Adv Ther;
39(5): 2256-2269, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35316500
13.
Dynamic Visual Representation of Clinical Efficacy of Ixekizumab in Psoriasis.
Dermatol Ther (Heidelb);
11(4): 1107-1118, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34050899
14.
Psoriasis Severity Assessment Combining Physician and Patient Reported Outcomes: The Optimal Psoriasis Assessment Tool.
Dermatol Ther (Heidelb);
11(4): 1249-1263, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34047947
15.
Injection Site Reactions in the Federal Adverse Event Reporting System (FAERS) Post-Marketing Database Vary Among Biologics Approved to Treat Moderate-To-Severe Psoriasis.
Dermatol Ther (Heidelb);
10(1): 99-106, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31734937
16.
Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses.
Dermatol Ther (Heidelb);
10(1): 73-86, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31686337
17.
Improvements in psoriasis within different body regions vary over time following treatment with ixekizumab.
J Dermatolog Treat;
29(3): 220-229, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28792259
18.
Evaluation of sPGA × BSA as an Outcome Measure and Treatment Target for Clinical Practice.
J Invest Dermatol;
138(9): 1955-1961, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29577919
19.
An observational study to assess back pain in patients with severe osteoporosis treated with teriparatide versus antiresorptives: An Indian subpopulation analysis.
Indian J Endocrinol Metab;
19(4): 483-90, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26180763
20.
Copper tolerance in fathead minnows: I. The role of genetic and nongenetic factors.
Environ Toxicol Chem;
23(1): 200-7, 2004 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-14768886